A fast-moving Ebola outbreak in the Democratic Republic of Congo has killed at least 65 people and generated 246 suspected cases, prompting Africa’s top public health body to convene an emergency coordination meeting with regional governments and global partners.
The Africa Centres for Disease Control and Prevention (Africa CDC) confirmed the outbreak on May 15, 2026, centered in Ituri province in northeastern DRC — marking the country’s 17th recorded Ebola outbreak since the virus was first identified there in 1976.
The outbreak is concentrated in the Mongwalu and Rwampara health zones, with suspected cases also reported in Bunia, Ituri’s provincial capital. Laboratory analysis by the Institut National de Recherche Biomédicale (INRB) in Kinshasa detected Ebola virus in 13 of 20 samples tested. Critically, preliminary results suggest the circulating strain is not Ebola Zaire — the species responsible for most previous DRC outbreaks and the only type for which a licensed vaccine currently exists. Sequencing to confirm the exact species was underway, with results expected within 24 hours of the announcement. Uganda’s Ministry of Health separately confirmed an Ebola case in a 59-year-old Congolese man who died in a Kampala hospital on May 14, identified as the Bundibugyo strain — an imported case with no confirmed local transmission as of May 15.
Non-Zaire Strain Changes the Response Calculus
The identification of a likely non-Zaire ebolavirus has significant implications for the response. The WHO-approved Ervebo vaccine and several leading therapeutic candidates were developed specifically against the Zaire strain. DRC maintains a stockpile of approximately 2,000 Ervebo doses and a supply of treatments, but these may offer limited protection against Sudan or Bundibugyo variants.
“That changes the calculus a little bit, because we don’t have the ability to just get in and start vaccinating everybody with the Ervebo vaccine,” said Jason Kindrachuk, an associate professor of medical microbiology and infectious diseases at the University of Manitoba, in an interview with CBC news. Africa CDC said it would assess the availability and appropriateness of medical countermeasures once sequencing results confirm the species. The WHO noted that field testing equipment used in Ituri initially returned negative results because it was calibrated only for the Zaire strain — a factor that delayed early detection.
Conflict, Mobility, and Delayed Detection Raise Alarm
Public health experts expressed concern that the outbreak was already large before it was publicly reported. The WHO said it was first notified of suspected cases on May 5 and dispatched a team to investigate, but initial field samples tested negative.
The geographic and security context amplifies the challenge. Ituri is located more than 1,000 kilometers from Kinshasa, is characterized by poor road networks, and has experienced sustained violence from armed groups including an Islamic State-linked militant organization. Mining activity in Mongwalu drives intense population movement, and the province borders both Uganda and South Sudan — raising cross-border spread concerns. Gaps in contact tracing, infection prevention and control capacity, and insecurity in affected areas are all listed by Africa CDC as factors increasing transmission risk.
Massive Coordination Mobilized Across Governments and Industry
In response, Africa CDC convened a high-level emergency coordination meeting on May 15 bringing together health authorities from DRC, Uganda, and South Sudan alongside an extensive list of international partners, including the WHO, UNICEF, FAO, the U.S. CDC, the European CDC, China CDC, the Public Health Agency of Canada, and major pharmaceutical companies including Gilead Sciences, Merck, Johnson & Johnson, Regeneron, Roche, BioNTech, and Moderna. The WHO announced the release of $500,000 in emergency funding to support DRC’s response.
The U.S. CDC, under acting director Dr. Jay Bhattacharya, confirmed it was coordinating with country offices in both DRC and Uganda. When asked about the potential impact of recent U.S. foreign aid cuts on outbreak response capacity, Bhattacharya said CDC country offices in both nations remained well-staffed and equipped. However, experts were not entirely reassured that the withdrawal of the U.S. from the World Health Organization, virtual elimination of USAID, cuts to N.I.H. grants and damaging reductions to U.S. CDC staffing have played no role. During a 2021 Ebola response, USAID provided up to $11.5 million in support across Africa; the extent of U.S. financial commitment to the current response has not yet been announced.
Despite these concerns, DRC brings substantial institutional experience to the response. The country has contained multiple outbreaks, including a devastating 2018–2020 Zaire strain outbreak that killed more than 1,000 people. “In terms of training, people already know what they can do,” said Dr. Gabriel Nsakala, a public health professor with direct Ebola response experience. “Now, the expertise and equipment need to be delivered quickly.”
Africa CDC is urging residents in affected and at-risk areas to follow national health authority guidance, report symptoms promptly, avoid contact with suspected cases, and cooperate with response teams.
Sources and further reading:
Africa CDC Calls Urgent Regional Coordination Meeting Following Ebola Virus Disease Outbreak in Ituri Province, DRC – Africa CDC
Ebola outbreak kills 65 people in eastern Democratic Republic of the Congo – The Guardian
New Ebola outbreak in the Congo kills dozens as Uganda confirms separate case – CBC
Large Ebola outbreak is declared in Congo – The New York Times
What to know about the Ebola outbreak blamed for scores of deaths in the Congo – AP News